Bajaj Healthcare

Price chart

Previous close

₹315.20

Open

₹315.20

Day high

₹319.25

Day low

₹310.30

Listed on NSE since 25 November 2021.

Market value

₹1,061.13 Cr

P/E (trailing)

43.12

EPS (trailing)

₹7.31

Price to book

1.90

Dividend yield

0.48%

Return on equity

4.8%

Debt to equity

0.51

Profit margin

3.1%

Beta

0.28

Volume today

45,304

Average volume

1.26 L

Source: Yahoo Finance. Ratios use the latest reported (trailing twelve-month) figures.

Source: Yahoo Finance, from annual reports. Consolidated where reported.

Source: Bajaj Healthcare’s results filed with NSE, standalone (the company alone). Net profit is the share of Bajaj Healthcare’s own shareholders where the filing separates it. Profit vs year ago compares with the same quarter a year earlier; – where that quarter is not on file or made a loss.

Download results (zip) A spreadsheet of the quarterly results and balance sheets, with the original filings from NSE.

Source: Bajaj Healthcare’s half-yearly statements of assets and liabilities filed with NSE, standalone. Companies file these every September and March.

Bajaj HealthCare Limited, a pharmaceutical company, develops, manufactures, markets, and sells active pharmaceutical ingredient, intermediates, and finished dosage forms and nutraceuticals for pharmaceutical, nutraceuticals, and food industries in India and internationally. The company offers active pharmaceutical ingredient in various therapeutic categories, including anthelmintic, anti viral, anti coagulant, vitamin c, anti arthritis, atypical antipsychotic agent, anti convulsant, vasoprotective, disinfectant, anti asthamatic, neuro protective, anti histamine, iron chelator, vasoprotective, urinary tract infection, anti migraine, anti rheumatic, antibiotic, anti tussive, weight reducing, hemorheologic agent, vasodilator, anti psychotic, beta agonist, gastroretentive drug, and antagonist. It also provides 2-amino-3,5-dibromobenzaldehyde, bromoethyl theophylline, calcium phosphoryl choline chloride, 4-hydrazinobenzoic acid and octopamine HCL, 8- chloro theophylline, chlorohexanone, theobromine, hesperidin, 5-amino-2,4,6-triiodoisophthaloyl dichloride, 3-methyl xanthine, 3-methyl-7-(2-butyn-1-yl)-8- bromo xanthine, 8 bromo-3-methyl xanthine, 4,5-dinitroaniline, 4,5-dichloro-2-nitroaniline, and 2-amino -4- hydroxyacetophenone. In addition, it offers nutraceuticals; and formulations in the form of tablets, capsules, sachets, and vials, as well as impurities. Bajaj HealthCare Limited was incorporated in 1993 and is based in Thane, India.

Industry

Drug Manufacturers - Specialty & Generic

Based in

Thane

Employees

949

Company website · Profile: Yahoo Finance

No headlines name Bajaj Healthcare in the last day or two.

• Dividend - Rs 1.50 Per Share

  Dividend · ex-date 11 September 2026 · record date 14 September 2026

• Dividend - Re 1 Per Share

  Dividend · ex-date 19 September 2025

• Annual General Meeting/Dividend - Re 1 Per Share

  Dividend · ex-date 23 September 2024

• Annual General Meeting/Dividend - Re 1 Per Share

  Dividend · ex-date 22 September 2023

• Annual General Meeting/Dividend - Rs 1.50 Per Share

  Dividend · ex-date 22 September 2022

Source: NSE. Latest first.